Amazon sees possible second-quarter loss as it forecasts $4 billion in COVID-19-related costs
Amazon.com Inc on Thursday said it could post its first quarterly loss in five years because it is spending at least $4 billion in response to...
Market wire
Latest news on private equity markets
Headlines on the small cap U.S. and Canadian companies we follow, pulled from the wires as they publish. Every story opens at its original source.
Biggest U.S. banks says they submitted $45.8 billion in loans for emergency aid program
The two largest U.S. banks, JPMorgan Chase & Co and Bank of America , said on Thursday that they submitted almost half a million applications worth...
Amazon sees $4 billion in COVID-19-related costs, may not make second-quarter profit
Amazon.com Inc on Thursday said it could post its first quarterly loss in five years because it is spending at least $4 billion in response to...
Boeing set to raise $25 billion in massive debt sale: sources
Boeing Co expects to raise around $25 billion in its bond offering on Thursday, according to people familiar with the matter, a blowout result for the...
Gilead to work with partners to ramp up production of potential coronavirus treatment
Gilead Sciences Inc, maker of the experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential COVID-19...
Apple sales inch higher despite coronavirus but CEO Tim Cook sees uncertain future
Apple Inc reported sales and profits that beat Wall Street expectations Thursday, with Chief Executive Officer Tim Cook saying China sales were "headed in the right...
Elon Musk interrupts NASA-SpaceX call during question about his coronavirus views: 'Move on'
SpaceX CEO Elon Musk unexpectedly spoke up during a NASA conference call on Thursday
Amgen studying Otezla for coronavirus, first-quarter results beat Street estimates
Amgen Inc on Thursday reported better-than-expected first-quarter results on Thursday and said it plans to study psoriasis drug Otezla as a potential treatment for COVID-19, the...
Stocks just posted their best month in decades, yet most of Wall Street hates this rally
"History tells us that the odds of another deep decline are very, very high," one strategist said.
Global equities dip at end of best month since '09
World equity benchmarks dipped on Thursday to close their best month in 11 years as a rebound in oil prices, encouraging early results from a COVID-19...
United Airlines posts quarterly loss, shores up $9.6 billion in liquidity
United Airlines Holdings Inc on Thursday posted a first-quarter loss of $1.7 billion, including charges against investments in Latin America that have soured as the coronavirus...
Wall St. caps best month in decades with broad sell-off
U.S. stocks lost ground on Thursday as grim economic data and mixed earnings prompted investors to take profits at the close of the S&P 500's best...
Apple reports higher sales as China reopens after coronavirus but gives no forecast
Apple Inc reported sales and profits that beat Wall Street expectations Thursday, with Chief Executive Officer Tim Cook saying China sales were "headed in the right...
Gilead aims to expand remdesivir output for COVID-19, posts flat 1st-quarter results
Gilead Sciences Inc , maker of the experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential...
Amazon's second-quarter forecast weighed down by $4 billion in COVID-19 related costs, shares fall
Amazon.com Inc on Thursday warned that it could post a loss in the second quarter as it tacked on about $4 billion in costs related to...